Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanreotide 30 mg vs Placebo for Digestive Fistulae
NCT00729313Phase 3Completed
- Sponsor
- Ipsen
- Start
- Apr 2000
- Primary completion
- Apr 2005
- Modality
- Peptides
- Countries
- 2
01
Overview
A Phase 3 trial of lanreotide in gastrointestinal fistula, sponsored by Ipsen. Started Apr 2000; status: completed.
02
Drugs
lanreotide
03
Conditions
gastrointestinal fistula
Beyond the preview
Go deeper on NCT00729313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00729313.